Adebayo Fasanya, MD
Pulmonary Disease · Fort Smith, ARNPI 1508111212
Payments from drug & device makers
Across 477 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Boehringer Ingelheim$761
- Regeneron Healthcare Solutions, Inc.$676
- Philips North America LLC$401
- Mylan Specialty L.p.$363
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 101 | $1,699 |
| GSK | 123 | $1,691 |
| Boehringer Ingelheim | 39 | $761 |
| Regeneron Healthcare Solutions, Inc. | 32 | $676 |
| Philips North America LLC | 23 | $401 |
| Mylan Specialty L.p. | 17 | $363 |
| Sanofi | 16 | $337 |
| Actelion Pharmaceuticals US, Inc. | 12 | $268 |
| Genentech USA, Inc. | 10 | $243 |
| United Therapeutics Corporation | 11 | $241 |
| Viatris Specialty LLC | 13 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $193 |
| Gilead | 9 | $161 |
| Harmony Biosciences LLC | 8 | $128 |
| Jazz Pharmaceuticals Inc. | 6 | $118 |
| Merck | 5 | $85 |
| Verona Pharma, Inc. | 4 | $81 |
| Amgen | 4 | $79 |
| Advanced Respiratory, Inc | 3 | $68 |
| Grifols USA, LLC | 3 | $65 |
| Mallinckrodt Hospital Products Inc. | 3 | $58 |
| Insmed, Inc. | 3 | $54 |
| Pfizer | 3 | $47 |
| ANI Pharmaceuticals, Inc. | 3 | $46 |
| Inari Medical, Inc. | 2 | $39 |
| Johnson & Johnson(2 entities) | 2 | $37 |
| Baxter Healthcare | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Medtronic | 1 | $23 |
| Electromed, Inc. | 2 | $23 |
| Ambu Inc. | 1 | $22 |
| Olympus America Inc. | 1 | $19 |
| Abiomed | 1 | $15 |
| G1 Therapeutics, Inc. | 1 | $13 |
| Chiesi USA, Inc. | 1 | $11 |
How this compares
$8,364 in reported general payments places this provider in the 70th percentile of 102 pulmonary disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Fort Smith
- Arturo MeadeFort Smith$67K
- Daphne MacbruceFort Smith$10K
- Muhammad MirFort Smith$4K
- Sarikun TjandraFort Smith$3K
- Francisco TamayoFort Smith$3K
- Larry JohnsonLittle Rock$847K
- Timothy CookSherwood$638K
- Nikhil MeenaLittle Rock$574K
- Raghu ReddyLittle Rock$541K
- Ladly AbrahamConway$521K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.